November 05, 2021
New Jersey's chief federal judge on Friday agreed with health officials that policies by Sanofi-Aventis US LLC and Novo Nordisk Inc. run afoul of a federal drug discount program meant to benefit the poor, but regulators can't penalize the companies just yet.
March 02, 2021
A bevy of hospital trade groups asked a New Jersey federal court Tuesday if they can intervene in lawsuits brought by Sanofi-Aventis and Novo Nordisk challenging the U.S. Department of Health and Human Services' view that drugmakers must give discounts to pharmacies serving low-income areas.
January 13, 2021
AstraZeneca, Eli Lilly and Sanofi-Aventis have launched a series of lawsuits challenging the U.S. Department of Health and Human Services' view that drugmakers have to give discounts to pharmacies contracting with hospitals that participate in a program serving low-income areas.